Specialty Pharmacy

Bosutinib (Bosulif) was approved by the FDA to treat patients with chronic phase Philadelphia chromosome positive chronic myelogenous leukemia.

Trastuzumab (Herceptin) is indicated to treat HER2+ breast and gastric cancers.

Patients treated with chemotherapy biweekly were 17% less likely to experience breast cancer recurrence over 10 years.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the importance of a quick turnaround from patient referral to acceptance.

Human Vaccines Project seeks to decode the human immune system to facilitate accelerated development of diagnostics, vaccines and therapies for major global diseases.

Top news of the day from across the health care landscape.

Luxturna (voretigene neparvovec-rzyl) is indicated to treat confirmed biallelic RPE65 mutation-associated retinal dystrophy.

The average profit from cancer drugs administered by 340B hospitals was nearly 50% in 2015.

CAR T cell therapy resulted in a high response rate among previously-treated patients with multiple myeloma.

Top news of the day from across the health care landscape.

Fingolimod was previously approved to treat relapsing multiple sclerosis as a once-daily disease-modifying therapy.

Marc O’Connor, chief operating officer at Curant Health, explains ways patient care models can reduce costs.

Multiple specialty pharmacy processes can delay the time-to-fill for specialty medications.

Pharmacists play a critical role in helping patients adhere to therapy.

Disrupting the circadian rhythm exacerbate multiple sclerosis symptoms.

Top news of the day from across the health care landscape.

Children with HIV have a unique risk of nonadherence in adolescence and elevated risk of mental health and substance use problems later in life.

Patients with multiple sclerosis who eat healthy could reduce their risk of severe disability by 20%.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how stakeholder alliances benefit patients.

Only 21% of HIV-positive individuals visited a health care provider within 2 weeks of release from jail or prison.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Vaccine regimen based on mosaic immunogens designed to create a buffer against various strains of HIV.

Tofacitinib (Xeljanz/Xeljanz XR) improves disease severity for patients with psoriatic arthritis.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

An immunotherapy combination increased progression-free survival among patients with advanced renal cell carcinoma.

A combination of ramucirumab plus cisplatin and capecitabine did not improve survival in gastric cancer.

Increasing myelin production by targeting oligodendrocytes shows promise as a treatment for multiple sclerosis.